{"id":"topiramate-drug","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dizziness"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Weight loss"}]},"_chembl":{"chemblId":"CHEMBL220492","moleculeType":"Small molecule","molecularWeight":"339.37"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Topiramate's mechanism of action involves blocking voltage-dependent sodium channels, which reduces the frequency of action potentials in neurons. Additionally, it acts as a GABA receptor agonist, enhancing the inhibitory effects of GABA on neuronal activity. This dual mechanism of action contributes to its anticonvulsant and neuroprotective effects.","oneSentence":"Topiramate is a sulfamate-substituted monosaccharide that acts as a voltage-dependent sodium channel blocker and GABA receptor agonist.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:39:27.400Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Epilepsy"},{"name":"Migraine prevention"}]},"trialDetails":[{"nctId":"NCT05925959","phase":"NA","title":"Preoperative Weight Loss for Open Abdominal Wall Reconstruction","status":"RECRUITING","sponsor":"Benjamin T. Miller","startDate":"2023-06-19","conditions":"Abdominal Wall Hernia","enrollment":258},{"nctId":"NCT04986631","phase":"EARLY_PHASE1","title":"Pharmacokinetics and Pharmacodynamics of Topiramate for Weight Loss in Youth: PHARMATOP","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Minnesota","startDate":"2022-04-04","conditions":"Obesity, Childhood","enrollment":62},{"nctId":"NCT06972056","phase":"PHASE4","title":"Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-07-09","conditions":"Migraine","enrollment":1335},{"nctId":"NCT01351753","phase":"PHASE2","title":"Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity","status":"TERMINATED","sponsor":"University of Iowa","startDate":"2011-03","conditions":"Obesity, Metabolic Syndrome X","enrollment":128},{"nctId":"NCT07213466","phase":"PHASE4","title":"Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-01-19","conditions":"Bipolar I Disorder, Bipolar II Disorder, Schizo Affective Disorder","enrollment":100},{"nctId":"NCT05975580","phase":"PHASE4","title":"Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2023-08-29","conditions":"Obesity","enrollment":120},{"nctId":"NCT07413731","phase":"","title":"Neurophysiological Effects of Medication Tapering During Treatment With Spinal Cord Stimulation","status":"RECRUITING","sponsor":"Brai²n","startDate":"2025-02-03","conditions":"Persistent Spinal Pain Syndrome Type 2 (PSPS-T2), Lower Spine, Spinal Cord Sensitivity to Neurostimulation, Neurophysiological Sensitivity to Spinal Cord Stimulation","enrollment":50},{"nctId":"NCT03511118","phase":"","title":"Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants","status":"RECRUITING","sponsor":"Duke University","startDate":"2018-10-04","conditions":"Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI","enrollment":1600},{"nctId":"NCT03461874","phase":"NA","title":"ACT Therapy for HF Migraine","status":"COMPLETED","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2018-03-15","conditions":"Migraine Without Aura","enrollment":64},{"nctId":"NCT07384624","phase":"PHASE1, PHASE2","title":"Combining Latency Reversing Agents to Address the HIV Reservoir","status":"NOT_YET_RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2026-04","conditions":"HIV (Human Immunodeficiency Virus), HIV -1 Infection","enrollment":30},{"nctId":"NCT04621929","phase":"PHASE3","title":"Phentermine/Topiramate for Uric Acid Stones","status":"COMPLETED","sponsor":"University of Florida","startDate":"2021-03-31","conditions":"Obesity, Uric Acid Stones, Type 2 Diabetes Mellitus in Obese","enrollment":19},{"nctId":"NCT04050293","phase":"PHASE4","title":"Therapy for Migraine Prevention in Children 6-11 Years of Age","status":"TERMINATED","sponsor":"Supernus Pharmaceuticals, Inc.","startDate":"2020-07-14","conditions":"Migraine Disorders, Headache Disorders","enrollment":26},{"nctId":"NCT05579249","phase":"PHASE4","title":"A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2023-01-19","conditions":"Obesity","enrollment":500},{"nctId":"NCT00659035","phase":"","title":"Use of Driving Tests to Evaluate Patient Performance on Oral Opioids","status":"ACTIVE_NOT_RECRUITING","sponsor":"Asokumar Buvanendran","startDate":"2008-04","conditions":"Chronic Pain","enrollment":450},{"nctId":"NCT07058155","phase":"PHASE4","title":"Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2025-12-17","conditions":"Liver Cirrhoses, Portal Hypertension Related to Cirrhosis, Severe Obesity","enrollment":70},{"nctId":"NCT05209984","phase":"PHASE3","title":"A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-04","conditions":"Overweight, Obesity","enrollment":""},{"nctId":"NCT06854614","phase":"PHASE4","title":"Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2025-03-01","conditions":"Obesity","enrollment":150},{"nctId":"NCT02273804","phase":"PHASE3","title":"Topiramate and Severe Obesity","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-06-01","conditions":"Obese Children and Adolescents","enrollment":18},{"nctId":"NCT07027969","phase":"PHASE4","title":"Metabolic Surgery for Atrial Fibrillation Elimination","status":"NOT_YET_RECRUITING","sponsor":"Ali Aminian","startDate":"2026-02-01","conditions":"Atrial Fibrillation, Obesity and Obesity-related Medical Conditions","enrollment":100},{"nctId":"NCT06303778","phase":"NA","title":"Combining a Smartphone App With Medications to Manage Heavy Drinking","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-11-01","conditions":"Alcohol Use Disorder (AUD)","enrollment":330},{"nctId":"NCT01182766","phase":"PHASE2, PHASE3","title":"New Treatment for Alcohol and Nicotine Dependence","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2011-11-01","conditions":"Alcohol Dependence, Nicotine Dependence","enrollment":236},{"nctId":"NCT04881799","phase":"EARLY_PHASE1","title":"Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Minnesota","startDate":"2022-07-07","conditions":"Pediatric Obesity","enrollment":13},{"nctId":"NCT06877572","phase":"","title":"Weight Loss Management in Endometrial Cancer Survivors","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2025-03-25","conditions":"Endometrial Cancer Survivors, Weight Management, Early Stage Endometrial Cancer","enrollment":50},{"nctId":"NCT06799169","phase":"PHASE4","title":"Management of Acute Tinnitus With Migraine Medications","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Irvine","startDate":"2025-06-01","conditions":"Tinnitus","enrollment":100},{"nctId":"NCT07203248","phase":"","title":"Chinese Real-world Study of Treatment of Vestibular Migraine","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-12","conditions":"Vestibular Migraine, Dizziness, Vertigo","enrollment":2000},{"nctId":"NCT07188545","phase":"","title":"Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University","startDate":"2025-09-15","conditions":"Cardiovascular Kidney Metabolic Syndrome","enrollment":23280000},{"nctId":"NCT05756764","phase":"","title":"Anti-obesity Pharmacotherapy and Inflammation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Louisiana State University Health Sciences Center in New Orleans","startDate":"2023-06-01","conditions":"Obesity","enrollment":30},{"nctId":"NCT02670161","phase":"PHASE4","title":"Quality Improvement and Practice Based Research in Neurology Using the EMR","status":"ENROLLING_BY_INVITATION","sponsor":"Endeavor Health","startDate":"2016-05","conditions":"Brain Tumors, Epilepsy, Migraine","enrollment":3300},{"nctId":"NCT05756621","phase":"","title":"Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest","status":"RECRUITING","sponsor":"University of Milano Bicocca","startDate":"2022-01-15","conditions":"Status Epilepticus, Cardiac Arrest","enrollment":80},{"nctId":"NCT06299891","phase":"PHASE2","title":"Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity","status":"RECRUITING","sponsor":"Seattle Children's Hospital","startDate":"2025-03-01","conditions":"Hypothalamic Obesity, Hypothalamic Tumor, Craniopharyngioma","enrollment":24},{"nctId":"NCT04007393","phase":"PHASE2","title":"SMART Use of Medication for the Treatment of Adolescent Severe Obesity","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2019-11-21","conditions":"Adolescent Obesity","enrollment":150},{"nctId":"NCT03689114","phase":"PHASE4","title":"Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2021-05-10","conditions":"Epilepsies, Partial","enrollment":58},{"nctId":"NCT04572217","phase":"PHASE2","title":"Medications After Adolescent Bariatric Surgery","status":"WITHDRAWN","sponsor":"Janey Pratt","startDate":"2022-06-01","conditions":"Pediatric Obesity","enrollment":""},{"nctId":"NCT05748483","phase":"PHASE3","title":"Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2023-10-07","conditions":"Migraine","enrollment":545},{"nctId":"NCT04095104","phase":"PHASE2","title":"Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2020-01-15","conditions":"Obesity, Morbid, Bariatric Surgery, Adolescent","enrollment":13},{"nctId":"NCT02201251","phase":"PHASE3","title":"A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2014-10-06","conditions":"Epilepsy","enrollment":63},{"nctId":"NCT04298203","phase":"PHASE2","title":"Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Minnesota","startDate":"2021-08-04","conditions":"Obesity","enrollment":100},{"nctId":"NCT04613024","phase":"EARLY_PHASE1","title":"Beneficial Side Effects of Topiramate in Obese Patients Undergoing Total Joint Arthroplasty","status":"WITHDRAWN","sponsor":"Stanford University","startDate":"2025-07-01","conditions":"Weight Loss, Pain, Postoperative","enrollment":""},{"nctId":"NCT02283814","phase":"PHASE1","title":"A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2007-01","conditions":"Epilepsy","enrollment":32},{"nctId":"NCT00394095","phase":"PHASE4","title":"Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2006-12","conditions":"Bipolar Disorder, Weight Gain","enrollment":31},{"nctId":"NCT03667846","phase":"PHASE2","title":"Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2019-10-10","conditions":"Post Traumatic Stress Disorder, Alcohol Use Disorder","enrollment":150},{"nctId":"NCT04581603","phase":"PHASE4","title":"CBT-I Augmentation of Medication for Drinking in AUD","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2022-06-15","conditions":"Alcohol Use Disorder With Insomnia","enrollment":82},{"nctId":"NCT05812183","phase":"PHASE4","title":"Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesity","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"2023-07-09","conditions":"Dyspnea, Quality of Life","enrollment":""},{"nctId":"NCT03307863","phase":"PHASE4","title":"Effect of Anti-epileptic Drugs on Etonogestrel-releasing Implant Pharmacokinetics in Women With Epilepsy","status":"SUSPENDED","sponsor":"University of Sao Paulo","startDate":"2017-11-01","conditions":"Contraception, Drug Interactions","enrollment":69},{"nctId":"NCT03671681","phase":"PHASE4","title":"Mindfulness Therapy for Chronic Migraine","status":"COMPLETED","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2018-11-05","conditions":"Chronic Migraine, Medication Overuse Headache","enrollment":177},{"nctId":"NCT06322407","phase":"NA","title":"Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-06-01","conditions":"Chronic Migraine","enrollment":206},{"nctId":"NCT05263674","phase":"PHASE3","title":"Fast Acute Sedation at Intensive Care vs. High-dose i.v. Anti-seizure Medication for Treatment of Non-convulsive Status Epilepticus (FAST-trial)","status":"RECRUITING","sponsor":"University of Southern Denmark","startDate":"2022-02-07","conditions":"Non-Convulsive Status Epilepticus","enrollment":140},{"nctId":"NCT01689649","phase":"PHASE4","title":"A Study to Assess Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With Epilepsy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2008-05-02","conditions":"Epilepsy","enrollment":139},{"nctId":"NCT01950520","phase":"PHASE2","title":"Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2014-02-07","conditions":"Healthy Volunteers","enrollment":47},{"nctId":"NCT00904943","phase":"PHASE1","title":"Topiramate 25 mg Capsules Under Fed Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-06","conditions":"Healthy","enrollment":18},{"nctId":"NCT04531176","phase":"PHASE4","title":"EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial","status":"TERMINATED","sponsor":"The Cleveland Clinic","startDate":"2020-09-01","conditions":"Type 2 Diabetes, Obesity","enrollment":74},{"nctId":"NCT00905164","phase":"PHASE1","title":"Topiramate 25 mg Capsules Under Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-06","conditions":"Healthy","enrollment":24},{"nctId":"NCT00905346","phase":"PHASE1","title":"Topiramate 25 mg Capsule Mixed With Applesauce Under Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-06","conditions":"Healthy","enrollment":24},{"nctId":"NCT00905606","phase":"PHASE1","title":"Topiramate 25 mg Tablets Under Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2001-06","conditions":"Healthy","enrollment":30},{"nctId":"NCT05582837","phase":"PHASE4","title":"Treatment of Meniere's Disease With Migraine Medications","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2022-08-01","conditions":"Ménière","enrollment":100},{"nctId":"NCT05215418","phase":"PHASE4","title":"A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects","status":"COMPLETED","sponsor":"VIVUS LLC","startDate":"2022-01-25","conditions":"Blood Pressure","enrollment":565},{"nctId":"NCT06248931","phase":"PHASE3","title":"Valproate Versus Topiramate in Migraine","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2022-05-01","conditions":"Migraine Disorders","enrollment":600},{"nctId":"NCT06499116","phase":"PHASE4","title":"Comparison of the Effectiveness of First-line Preventive Treatment of Migraine in Primary Care","status":"NOT_YET_RECRUITING","sponsor":"Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina","startDate":"2024-10","conditions":"Migraine","enrollment":460},{"nctId":"NCT01765218","phase":"PHASE1, PHASE2","title":"Topiramate in Neonates Receiving Whole Body Cooling for Hypoxic Ischemic Encephalopathy","status":"TERMINATED","sponsor":"Kristin R Hoffman","startDate":"2013-02","conditions":"Hypoxic Ischemic Encephalopathy","enrollment":34},{"nctId":"NCT00812006","phase":"PHASE3","title":"A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2009-03-24","conditions":"Migraine","enrollment":108},{"nctId":"NCT06347497","phase":"PHASE3","title":"Zonisamide Versus Topiramate in Migraine","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-04-01","conditions":"Migraine","enrollment":600},{"nctId":"NCT00649740","phase":"PHASE1","title":"Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2005-11","conditions":"Healthy","enrollment":36},{"nctId":"NCT00648934","phase":"PHASE1","title":"Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2005-11","conditions":"Healthy","enrollment":36},{"nctId":"NCT00649467","phase":"PHASE1","title":"Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2005-11","conditions":"Healthy","enrollment":35},{"nctId":"NCT00606411","phase":"EARLY_PHASE1","title":"Efficacy and Safety of Topiramate in the Treatment of Sleep-Related Eating Disorder","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2008-01","conditions":"Sleep-Related Eating Disorder","enrollment":34},{"nctId":"NCT06243692","phase":"PHASE3","title":"Lacosamide Versus Topiramate in Migraine","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-02-01","conditions":"Migraine Disorders","enrollment":600},{"nctId":"NCT06282783","phase":"PHASE1, PHASE2","title":"Studying Topiramate for Re-Activating the HIV-1 Reservoir","status":"UNKNOWN","sponsor":"Erasmus Medical Center","startDate":"2024-09","conditions":"HIV-1-infection, Hiv, HIV Infections","enrollment":12},{"nctId":"NCT05403229","phase":"PHASE2","title":"The Role of Migraine Prophylaxis Agent Topiramate in Treating Patients With Sudden Sensorineural Hearing Loss","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2022-10-17","conditions":"Sudden Deafness, Sudden Sensorineural Hearing Loss","enrollment":140},{"nctId":"NCT05378503","phase":"PHASE4","title":"Phase IV Study of Qsymia in Obese Patients","status":"COMPLETED","sponsor":"Alvogen Korea","startDate":"2021-09-17","conditions":"Obesity","enrollment":232},{"nctId":"NCT03176953","phase":"PHASE2, PHASE3","title":"Topiramate and Prolonged Exposure","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2017-11-01","conditions":"PTSD and Alcohol Use Disorder","enrollment":100},{"nctId":"NCT02878798","phase":"PHASE2","title":"Topiramate for Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome (CSPN)","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2018-02-12","conditions":"Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome","enrollment":132},{"nctId":"NCT05940935","phase":"","title":"The Relationship of Developing Metabolic Acidosis With Antiepleptic Drugs in Craniotomy Operations","status":"COMPLETED","sponsor":"Trakya University","startDate":"2023-05-22","conditions":"Metabolic Acidosis, Antiepileptic Drugs, Craniotomy","enrollment":35},{"nctId":"NCT05834062","phase":"PHASE2","title":"Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity","status":"WITHDRAWN","sponsor":"University of Minnesota","startDate":"2023-10-17","conditions":"Obesity, Adolescent","enrollment":""},{"nctId":"NCT06089356","phase":"PHASE4","title":"Zolmitriptane as Prophylaxis for Chilhood Migraine","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2023-01-01","conditions":"Migraine","enrollment":90},{"nctId":"NCT05663749","phase":"PHASE4","title":"Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics","status":"COMPLETED","sponsor":"All India Institute of Medical Sciences, Bhubaneswar","startDate":"2022-09-20","conditions":"Metabolic Syndrome, Schizophrenia","enrollment":60},{"nctId":"NCT05958160","phase":"PHASE2, PHASE3","title":"Modified Atkins Diet Versus Topiramate In Children With Epileptic Spasms Refractory To Hormonal Treatment: A Randomized Open-Label Study","status":"UNKNOWN","sponsor":"Lady Hardinge Medical College","startDate":"2023-07-20","conditions":"Epileptic Spasms, Failed Hormonal Therapy","enrollment":70},{"nctId":"NCT02808533","phase":"NA","title":"Topiramate and Schizophrenia: Effects on Weight and Psychopathology","status":"UNKNOWN","sponsor":"Centre for Addiction and Mental Health","startDate":"2016-05","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":50},{"nctId":"NCT03374956","phase":"PHASE3","title":"Individualized Obesity Pharmacotherapy","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2017-12-11","conditions":"Obesity","enrollment":193},{"nctId":"NCT04408586","phase":"PHASE4","title":"Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2020-06-03","conditions":"Obesity","enrollment":80},{"nctId":"NCT04721873","phase":"PHASE2","title":"Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2020-12-18","conditions":"Colitis, Ulcerative, Obesity","enrollment":40},{"nctId":"NCT03018704","phase":"PHASE4","title":"Topiramate Treatment of Alcohol Use Disorders in African Americans","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2017-08-01","conditions":"Alcohol Use Disorder","enrollment":79},{"nctId":"NCT05759845","phase":"PHASE4","title":"Topiramate, Amitriptyline Monotherapy and Combination Therapy in Migraine Prophylaxis","status":"UNKNOWN","sponsor":"Dr. Reaz Mahmud","startDate":"2022-08-22","conditions":"Migraine","enrollment":150},{"nctId":"NCT03603080","phase":"PHASE4","title":"Efficacy of Pharmacotherapy to Enhance Weight Loss Following Sleeve Gastrectomy","status":"TERMINATED","sponsor":"Hartford Hospital","startDate":"2019-03-01","conditions":"Obesity","enrollment":12},{"nctId":"NCT04404439","phase":"PHASE4","title":"Treatment of Tinnitus With Migraine Medications","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2019-09-26","conditions":"Tinnitus, Subjective, Tinnitus","enrollment":150},{"nctId":"NCT03799198","phase":"PHASE4","title":"Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2019-01-07","conditions":"Obesity","enrollment":200},{"nctId":"NCT03922945","phase":"PHASE4","title":"A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity","status":"COMPLETED","sponsor":"VIVUS LLC","startDate":"2019-05-02","conditions":"Adolescent Obesity, Obesity in Adolescence, Adolescent Overweight","enrollment":223},{"nctId":"NCT05516251","phase":"NA","title":"Transcutaneous Supraorbital Nerve Stimulator Versus Topiramate in Prevention of Recurrent Migraine","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2021-10-01","conditions":"Migraine, Classic","enrollment":200},{"nctId":"NCT02714062","phase":"PHASE4","title":"A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents","status":"COMPLETED","sponsor":"VIVUS LLC","startDate":"2016-03","conditions":"Pediatric Obesity, Childhood Obesity","enrollment":42},{"nctId":"NCT03335163","phase":"PHASE1","title":"The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2018-03-15","conditions":"Migraine, Migraine;Menstrual, Contraception","enrollment":48},{"nctId":"NCT03636958","phase":"NA","title":"Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy","status":"WITHDRAWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2021-02-15","conditions":"Refractory Epilepsy","enrollment":""},{"nctId":"NCT02497443","phase":"PHASE1, PHASE2","title":"Safety of Autologous MSC Infusion to Treat Epilepsy","status":"COMPLETED","sponsor":"Ministry of Public Health, Republic of Belarus","startDate":"2011-04","conditions":"Epilepsy","enrollment":60},{"nctId":"NCT01408641","phase":"NA","title":"Topiramate for Alcohol Use in Posttraumatic Stress Disorder","status":"TERMINATED","sponsor":"University of Maryland, Baltimore","startDate":"2012-09","conditions":"Alcohol Dependence, Alcoholism, Alcohol Abuse","enrollment":4},{"nctId":"NCT05236166","phase":"NA","title":"Multicentre Study on Rapid Versus Slow Withdrawal of Antiepileptic Monotherapy","status":"COMPLETED","sponsor":"University Magna Graecia","startDate":"2017-04-26","conditions":"Epilepsy","enrollment":48},{"nctId":"NCT02371889","phase":"PHASE2","title":"A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2014-12-18","conditions":"Alcoholism, Alcohol Use Disorder (AUD)","enrollment":320},{"nctId":"NCT04523935","phase":"PHASE4","title":"Excessive Crying in Children With Cerebral Palsy and Communication Deficits","status":"COMPLETED","sponsor":"Sathbhavana Brain Clinic","startDate":"2005-12-07","conditions":"Cerebral Palsy, Excessive Crying, Pain","enrollment":131},{"nctId":"NCT03828539","phase":"PHASE4","title":"Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2019-02-22","conditions":"Migraine","enrollment":777},{"nctId":"NCT02113787","phase":"NA","title":"Switchability Study Between Brand and Generic Topiramate","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2014-02","conditions":"Epilepsy","enrollment":24},{"nctId":"NCT04154813","phase":"NA","title":"Study on the Optimal Strategy of Chinese Patients With Bulimia Nervosa After Fluoxetine Treatment","status":"UNKNOWN","sponsor":"Shanghai Mental Health Center","startDate":"2020-02-01","conditions":"Fluoxetine","enrollment":550},{"nctId":"NCT01749215","phase":"PHASE4","title":"A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2013-02","conditions":"Alcohol Dependence, Posttraumatic Stress Disorder (PTSD)","enrollment":151},{"nctId":"NCT04759196","phase":"PHASE4","title":"Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural Hematomas","status":"UNKNOWN","sponsor":"Université de Sherbrooke","startDate":"2021-03-01","conditions":"Chronic Subdural Hematoma, Epilepsy; Seizure, Cortical Depression; Cortical Depolarization","enrollment":56}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Topamax"],"phase":"phase_3","status":"active","brandName":"Topiramate (drug)","genericName":"Topiramate (drug)","companyName":"Erasmus Medical Center","companyId":"erasmus-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Topiramate is a sulfamate-substituted monosaccharide that acts as a voltage-dependent sodium channel blocker and GABA receptor agonist. Used for Epilepsy, Migraine prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}